Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/30895
Title: Indications and diagnostic yield of endomyocardial biopsies for unexplained cardiomyopathy, a single center experience
Authors: RAMAEKERS, Jeroen 
Janssens, Joyce
Waumans, Lise
Stessens, Linde
DUPONT, Matthias 
MULLENS, Wilfried 
Martens, Pieter
Issue Date: 2020
Publisher: TAYLOR & FRANCIS LTD
Source: ACTA CARDIOLOGICA, 75 (2) , p. 138 -146
Abstract: Background: Endomyocardial biopsies (EMBs) remain the golden standard to diagnose underlying pathophysiologic process in heart failure (HF), when potential therapeutic decisions cannot be made by non-invasive techniques. However, changes in the field of non-invasive diagnostic testing might have an impact on the need for performing an EMB in certain scenarios. Methods: We performed a retrospective analysis of consecutive EMBs performed in a single, non-academic, tertiary-care centre. EMBs were performed between February 2009 and March 2018. Baseline characteristics including non-invasive imaging and hemodynamic profile were assessed. Indications of EMBs were analysed in accordance with the 2007-AHA/ACC/ESC-scientific statement on EMBs. Results: A total of 57 patients (74% male) were included. The overall diagnostic yield was 58%, with a trend towards a higher yield in left-side (64%) versus right-side EMBs (45%; p = .346). The majority of patients (88%) underwent EMBs for a class IIa-recommendation, 9% for a class-I recommendation and the remaining patients for a class IIb-indication. Of the EMBs for a class IIa indication, 82% (n = 47) was for an unexplained restrictive cardiomyopathy, in which 53% (n = 25) revealed a diagnosis (of whom n = 23 patients had amyloidosis). Subtyping of the EMBs with a pathologic diagnosis of amyloidosis revealed that 52% (n = 12) had transthyretin amyloidosis (ATTR) and 43% (n = 10) had light-chain amyloidosis (AL). Overall one major (1.7%) and one minor (1.7%) complication occurred following the EMB-procedure. Conclusions: When following the AHA/ACC/ESC-scientific statement on EMBs, the performance of EMBs had a high diagnostic yield, with acceptable complication rates. However, in patients presenting with an unexplained restricted cardiomyopathy, technetium-labelled bone scanning could offer a non-invasive approach to establishing the diagnosis of ATTR, mitigating the need for EMBs in a subset of patients.
Notes: Martens, P (reprint author), Ziekenhuis Oost Limburg, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium.
pieter.martens2@zol.be
Other: Martens, P (reprint author), Ziekenhuis Oost Limburg, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium. pieter.martens2@zol.be
Keywords: Heart failure;endomyocardial biopsy;amyloidosis;cardiovascular surgery;diagnostic yield
Document URI: http://hdl.handle.net/1942/30895
ISSN: 0001-5385
e-ISSN: 1784-973X
DOI: 10.1080/00015385.2018.1561597
ISI #: WOS:000518500300006
Rights: 2020 Informa UK Limited.
Category: A1
Type: Journal Contribution
Validations: ecoom 2021
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
jobbe.pdf
  Restricted Access
Published version1.36 MBAdobe PDFView/Open    Request a copy
Show full item record

SCOPUSTM   
Citations

1
checked on Sep 5, 2020

WEB OF SCIENCETM
Citations

3
checked on Jul 1, 2022

Page view(s)

30
checked on Jul 4, 2022

Download(s)

2
checked on Jul 4, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.